Renaissance Technologies LLC 13D and 13G filings for Celldex Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2021-02-10 4:51 pm Sale |
2020-12-31 | 13G | Celldex Therapeutics, Inc. CLDX |
Renaissance Technologies LLC | 1,048,827 2.650% |
-66,541 (-5.97%) |
Filing |